Scientists on brink of a cure for HIV?

Clinical trials on to test strategy in which the HIV virus is stripped from human DNA and destroyed by the immune system

HIV/AIDS
<a href="http://www.shutterstock.com/pic-135725843/stock-photo-aids-awareness-red-ribbon-isolated-on-black-with-aids-word.html" target="_blank">HIV/AIDS</a> image via Shutterstock
Press Trust of India London
Last Updated : Apr 28 2013 | 4:50 PM IST
A breakthrough for HIV may come "within months", claim Danish researchers, who are testing a new and cheaper technique to strip the deadly virus from human DNA and destroy it permanently.

Scientists are expecting results to show that "finding a mass-distributable and affordable cure to HIV is possible".

They are conducting clinical trials to test a "novel strategy" in which the HIV virus is stripped from human DNA and destroyed by the immune system, 'The Telegraph' reported.

Also Read

The development would represent a dramatic step forward in attempts to find a cure for the virus, which causes AIDS.

Scientists are currently conducting human trials on their treatment, in the hope of proving that it is effective. The treatment has already been found to work in laboratory tests.

The technique involves releasing the HIV virus from "reservoirs" it forms in DNA cells, bringing it to the surface of the cells, the report said.

As it comes to the surface, the body's natural immune system can kill the virus by being boosted by a "vaccine".

In vitro studies of the new technique proved so successful that in January, the Danish Research Council awarded the team 1.5 million pounds to pursue their study in clinical trials with human subjects.

These findings are now under way, and according to Dr Sogaard, the early signs are "promising".

"I am almost certain that we will be successful in releasing the reservoirs of HIV," Dr Ole Sogaard, a senior researcher at the Aarhus University Hospital in Denmark who is part of the research team, said.

"The challenge will be getting the patients' immune system to recognise the virus and destroy it. This depends on the strength and sensitivity of individual immune systems," said Sogaard.

As many as fifteen patients are currently taking part in the trials, and if they are found to have successfully been cured of HIV, the "cure" will be tested on a wider scale.

Sogaard stressed that a cure is not the same as a preventative vaccine, and that raising awareness of unsafe behaviour, including unprotected sex and sharing needles, remains of paramount importance in combating HIV.

Finding a cure would free a patient from the need to take continuous HIV medication, and save health services billions.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 28 2013 | 4:30 PM IST

Next Story